UTP23 Antibody

What is UTP23 and why is it important in research?

UTP23 is a conserved protein component of the 90S pre-ribosome (also known as the small subunit processome) that plays a critical role in early ribosome biogenesis. It contains a degenerate PIN nuclease domain followed by a long C-terminal tail and specifically associates with snR30 H/ACA snoRNA . UTP23 is essential for the assembly and dynamics of 90S pre-ribosomes, making it an important research target for understanding fundamental cellular processes of ribosome synthesis, which affects protein production and cellular growth . Antibodies against UTP23 are valuable tools for studying these ribosome assembly processes through various biochemical and cellular techniques.

What are the key structural features of UTP23 that antibodies might recognize?

UTP23 consists of two main structural components: an N-terminal PIN domain (residues 1-159) and a C-terminal tail (residues 160-254) . The PIN domain contains a unique CCHC-type zinc-finger motif formed by coordinating zinc to Cys64, Cys89, His91, and Cys102 . The most distinctive structural features include an N-terminal helix (α1) rich in conserved basic residues, the zinc-finger motif, and a highly conserved motif (PNPLSVKKKK at residues 202-211) in the otherwise low-complexity C-terminal tail . Antibodies may be designed to target epitopes in any of these regions, with the unique N-terminal helix and zinc-finger regions being particularly suitable targets for specific recognition.

How does the function of UTP23 relate to potential antibody applications?

UTP23 functions in ribosome biogenesis by specifically associating with snR30 snoRNA and participating in the assembly of 90S pre-ribosomes . This association occurs independently of 90S pre-ribosome formation, as demonstrated by immunoprecipitation experiments . Antibodies against UTP23 can therefore be valuable tools for studying:

• Protein-RNA interactions, particularly with snR30

• Assembly dynamics of pre-ribosomes

• Ribosome biogenesis pathways

• Localization of UTP23 within cellular compartments

• Protein-protein interactions within the 90S pre-ribosome complex

Which epitopes of UTP23 are most suitable for antibody generation?

Based on the structural analysis of UTP23, several regions may serve as optimal epitopes for antibody generation:

• The N-terminal helix α1 (residues 1-23): This region contains highly conserved basic residues (Arg5, Lys7, Arg10, and Lys11) that are exposed on the protein surface and functionally critical . Antibodies targeting this region would likely recognize functionally important domains.

• The unique CCHC zinc-finger motif region: This distinctive structural feature could serve as a specific epitope, though antibodies binding here might interfere with UTP23 function as mutations in the cysteine ligands are lethal or severely inhibit yeast growth .

• The conserved C-terminal motif (residues 202-211): This highly conserved PNPLSVKKKK sequence is functionally important, as its deletion severely inhibits yeast growth . Antibodies targeting this region could be useful for functional studies.

When selecting epitopes, researchers should consider whether they want antibodies that might interfere with function (for inhibition studies) or antibodies that recognize UTP23 without affecting its activity (for localization or pull-down experiments).

What are the potential cross-reactivity concerns with UTP23 antibodies?

When working with UTP23 antibodies, researchers should consider the following cross-reactivity issues:

• Species specificity: The search results focus on yeast (S. cerevisiae) UTP23, but orthologs exist across eukaryotes with varying degrees of sequence conservation . Antibodies raised against one species' UTP23 may have limited cross-reactivity with orthologs from other species.

• PIN domain proteins: UTP23 contains a PIN domain with structural similarity to other PIN domain-containing proteins such as AF0591 from Archaeoglobus fulgidus and human SMG6 . Antibodies targeting conserved regions of the PIN domain might cross-react with these related proteins.

• Other zinc-finger proteins: The CCHC zinc-finger motif in UTP23 shares structural features with other zinc-finger proteins, potentially leading to cross-reactivity if antibodies target this region.

To minimize cross-reactivity concerns, researchers should validate antibody specificity through Western blotting against cell lysates, including appropriate controls and possibly utilizing UTP23 knockout/knockdown samples.

How can UTP23 antibodies be used to study ribosomal assembly dynamics?

UTP23 antibodies can provide valuable insights into ribosomal assembly dynamics through several approaches:

• Immunoprecipitation (IP) coupled with RNA analysis: As demonstrated in the research, IP of Utp23-TAP allowed for the detection of specifically associated RNAs like snR30 . Researchers can use UTP23 antibodies to:

  • Pull down UTP23-containing complexes

  • Analyze associated RNAs by Northern blotting

  • Identify co-precipitated proteins by mass spectrometry

• Gradient sedimentation analysis: UTP23 antibodies can be used to track the protein's distribution across sucrose gradient fractions, revealing its association with different pre-ribosomal complexes . The study showed that wild-type UTP23 cosedimented with large 90S pre-ribosomes, while C-terminal truncation mutants displayed altered sedimentation patterns .

• Chromatin immunoprecipitation (ChIP): UTP23 antibodies could be used to study the association of UTP23 with nascent pre-rRNA transcripts at the site of transcription.

• Immunofluorescence microscopy: UTP23 antibodies can track the localization of UTP23 within the nucleolus during ribosome biogenesis.

These approaches allow researchers to investigate how UTP23 dynamically associates with pre-ribosomes and how mutations or environmental conditions affect these associations.

What methodological considerations are important when using UTP23 antibodies for protein-RNA interaction studies?

When using UTP23 antibodies to study protein-RNA interactions, researchers should consider:

• Buffer conditions: The research indicates that UTP23 specifically associates with snR30 independently of 90S pre-ribosome formation . The IP protocol used buffer with 50 mM Tris-HCl (pH 7.4), 100 mM NaCl, 5% glycerol, and 0.1% NP-40 . These conditions preserved the UTP23-snR30 interaction while reducing nonspecific RNA binding.

• RNase treatment controls: Include RNase treatment controls to distinguish direct protein-protein interactions from RNA-mediated interactions.

• Ultracentrifugation steps: The study employed an ultracentrifugation step to remove large RNPs including 90S particles, which helped demonstrate that UTP23-snR30 association occurs independently of 90S pre-ribosome formation . Consider whether to include this step based on your research question.

• Cross-linking: For transient interactions, consider using cross-linking approaches (such as UV cross-linking or formaldehyde cross-linking) before immunoprecipitation.

• Validation with mutants: The study showed that deletion of the C-terminal residues 202-211 disrupted the interaction of UTP23 with snR30 . Including known mutants as controls can validate the specificity of observed interactions.

How can researchers design experiments to study the role of UTP23's functional domains using antibodies?

To investigate the roles of UTP23's functional domains using antibodies, researchers can design experiments that combine domain-specific antibodies with mutational analysis:

• Epitope-specific antibodies approach:

  • Generate antibodies targeting different domains (N-terminal helix, zinc-finger motif, C-terminal tail)

  • Use these antibodies to monitor how mutations affect domain accessibility or conformation

  • Perform competition assays with domain-specific peptides to map functional interactions

• Functional rescue experiments:

  • Express UTP23 mutants in UTP23-depleted cells

  • Use antibodies to assess whether the mutants properly localize and associate with pre-ribosomes

  • Compare immunoprecipitation profiles of wild-type and mutant UTP23

• Structure-function correlation:

  • Use antibodies recognizing specific conformations or post-translational modifications

  • Correlate antibody reactivity with functional outcomes in different mutants

  • Screen for conditions that alter antibody recognition, potentially indicating conformational changes

The research identified several critical functional domains that could be targeted in such studies: the highly basic N-terminal helix α1, the CCHC zinc-finger motif, and the conserved C-terminal motif (residues 202-211) .

How should researchers interpret UTP23 antibody data in the context of ribosome biogenesis defects?

When interpreting UTP23 antibody data in the context of ribosome biogenesis, consider the following analytical framework:

Remember that UTP23 plays a specific role in 18S rRNA processing within the 90S pre-ribosome. Therefore, defects in UTP23 function would typically manifest as:

• Accumulation of precursor rRNAs

• Reduced levels of mature 18S rRNA

• Altered pre-ribosome composition

• Growth defects, particularly at lower temperatures (as seen with several UTP23 mutants)

What controls should be included when performing immunoprecipitation with UTP23 antibodies?

For rigorous immunoprecipitation experiments with UTP23 antibodies, researchers should include the following controls:

• Input control: Sample of the starting material before immunoprecipitation to assess the initial abundance of proteins and RNAs.

• Negative controls:

  • IgG control: Non-specific antibodies of the same isotype to assess non-specific binding

  • Immunoprecipitation from cells where UTP23 is depleted or knocked out

  • For TAP-tagged experiments, immunoprecipitation from untagged strains

• RNA specificity controls:

  • Include analysis of multiple snoRNAs beyond the target of interest (snR30)

  • The study examined U3, snR10, and U14 snoRNAs as well as U1 snRNA and Trp tRNA as specificity controls

  • These controls demonstrated that UTP23 specifically associates with snR30 over other snoRNAs involved in 18S processing

• Fractionation controls:

  • When performing experiments with subcellular fractions (like the ultracentrifugation step to remove large RNPs), include markers for different cellular compartments

  • Verify the efficiency of fractionation by testing for the presence of known components

• Functional mutant controls:

  • Include known functionally impaired mutants, such as the C-terminal truncation (N178) or deletion of residues 202-211, which showed disrupted interaction with snR30

  • These serve as positive controls for disrupted interactions

How can researchers analyze the impact of mutations on UTP23 function using antibodies?

Researchers can employ several antibody-based approaches to analyze how mutations affect UTP23 function:

• Protein expression and stability analysis:

  • Western blotting to compare expression levels of wild-type and mutant UTP23

  • Pulse-chase experiments with subsequent immunoprecipitation to assess protein stability

  • The study noted that some mutants (Δ1-23 and N159) showed no detectable expression, explaining their lethal phenotype

• Protein-RNA interaction analysis:

  • Immunoprecipitate wild-type and mutant UTP23, then analyze associated RNAs

  • Compare the efficiency of snR30 co-precipitation between wild-type and mutants

  • The research showed that deletion of the C-terminal tail disrupted the interaction with snR30

• Pre-ribosome association analysis:

  • Perform sucrose gradient sedimentation followed by Western blotting with UTP23 antibodies

  • Compare the sedimentation profiles of wild-type and mutant proteins

  • The C-terminal truncation mutant (N178) showed altered sedimentation behavior, particularly at 20°C

• In vitro RNA binding assays:

  • Use purified recombinant proteins (wild-type and mutants) in RNA binding assays

  • The study demonstrated that mutations in the N-terminal helix affected the in vitro RNA-binding activity of UTP23

• Structural impact analysis:

  • If available, use conformation-specific antibodies to detect structural changes in mutants

  • For zinc-finger mutations, analyze the impact on zinc coordination using appropriate biochemical assays

What are the optimal conditions for UTP23 antibody use in immunoprecipitation experiments?

Based on the research methods described, optimal conditions for UTP23 antibody immunoprecipitation include:

• Cell lysis buffer composition:

  • 50 mM Tris-HCl, pH 7.4

  • 100 mM NaCl

  • 5% glycerol

  • 0.1% NP-40

  • Protease inhibitors

• Immunoprecipitation conditions:

  • For TAP-tagged UTP23: IgG Sepharose beads

  • Incubation: 2 hours at 4°C with rotation

  • Wash buffer: Same as lysis buffer but with reduced detergent

  • For standard antibodies: Protein A or G beads depending on antibody isotype

• Considerations for RNA co-immunoprecipitation:

  • Include RNase inhibitors in all buffers

  • Consider the addition of vanadyl ribonucleoside complexes to protect RNA

  • For RNA analysis, extract RNA directly from beads using TRIzol or similar reagents

  • Analyze by Northern blotting for specific RNAs (snR30, U3, etc.)

• Pre-clearing options:

  • Pre-clear lysates with empty beads to reduce non-specific binding

  • Consider including a ultracentrifugation step (190,000g for 2 h) to remove large RNPs if studying direct interactions

• Elution strategies:

  • For peptide-specific antibodies: Consider competitive elution with excess peptide

  • For TAP-tag: TEV protease cleavage followed by calmodulin binding and EGTA elution

  • For routine analysis: Direct elution in SDS sample buffer

What challenges might researchers encounter when using UTP23 antibodies, and how can they overcome them?

Researchers working with UTP23 antibodies may face several challenges:

• Low signal-to-noise ratio:

  • Challenge: UTP23 may be present at relatively low abundance in cells

  • Solution: Increase starting material, optimize antibody concentration, consider signal amplification methods

• Non-specific binding:

  • Challenge: Antibodies may recognize proteins other than UTP23

  • Solution: Validate antibody specificity with UTP23 knockout/knockdown controls, use more stringent washing conditions, pre-clear lysates thoroughly

• Interference with UTP23 function:

  • Challenge: Antibodies may disrupt important functional interactions

  • Solution: Use multiple antibodies recognizing different epitopes, compare results with tagged versions of UTP23

• Detecting UTP23 mutants:

  • Challenge: Mutations might affect antibody recognition

  • Solution: Use antibodies targeting different regions, consider epitope-tagged versions of mutants

• Preserving transient interactions:

  • Challenge: UTP23's association with pre-ribosomes may be dynamic and easily disrupted

  • Solution: Consider crosslinking approaches, optimize buffer conditions to preserve interactions

• Distinguishing direct vs. indirect interactions:

  • Challenge: Determining whether UTP23 directly interacts with observed partners

  • Solution: Include RNase treatments, perform in vitro binding studies with purified components, use the ultracentrifugation step as demonstrated in the research

How should UTP23 antibodies be validated for research applications?

Thorough validation of UTP23 antibodies is essential for reliable research results. A comprehensive validation approach should include:

• Specificity validation:

  • Western blotting against wild-type and UTP23-depleted samples

  • Immunoprecipitation followed by mass spectrometry to identify all bound proteins

  • Peptide competition assays using the immunizing peptide

  • Testing cross-reactivity with related PIN domain proteins

• Functional validation:

  • Verify that the antibody can immunoprecipitate UTP23-associated RNAs (especially snR30)

  • Confirm the antibody detects UTP23 in relevant cellular compartments (primarily nucleolus)

  • Ensure the antibody can distinguish between wild-type UTP23 and functionally important mutants

• Technical validation:

  • Determine optimal concentrations for different applications (Western blot, IP, IF)

  • Establish appropriate positive and negative controls

  • Document lot-to-lot variability if using polyclonal antibodies

• Species cross-reactivity:

  • If working with multiple model organisms, test the antibody against UTP23 orthologs

  • Compare recognition efficiency across species

• Conformational considerations:

  • Test antibody recognition under native vs. denaturing conditions

  • Evaluate whether zinc coordination affects antibody binding, particularly for antibodies targeting regions near the zinc-finger motif

How might UTP23 antibodies contribute to understanding the evolutionary conservation of ribosome assembly?

UTP23 antibodies could significantly advance our understanding of evolutionary conservation in ribosome assembly through comparative studies:

• Cross-species analysis:

  • The study noted that UTP23 is conserved across eukaryotes, with most sequenced eukaryotic genomes containing a single ortholog

  • Antibodies recognizing conserved epitopes could be used to:

    • Compare UTP23 localization patterns across evolutionary diverse organisms

    • Assess conservation of protein-RNA interactions (particularly with snR30 homologs)

    • Identify species-specific binding partners through comparative immunoprecipitation

• Structure-function conservation:

  • The crystal structure revealed that UTP23 contains both highly conserved regions (like the CCHC zinc-finger motif) and more variable domains

  • Epitope-specific antibodies could help determine which functional aspects of UTP23 are most conserved

• Ribosome assembly pathway conservation:

  • By immunoprecipitating UTP23 from different organisms and analyzing associated factors

  • By comparing the timing of UTP23 recruitment to pre-ribosomes across species

• Identifying convergent evolution:

  • In organisms that might use different proteins to perform UTP23-like functions

  • By comparing antibody cross-reactivity patterns with functionally similar proteins

What are the most promising areas for future research using UTP23 antibodies?

Several promising research directions could benefit from UTP23 antibodies:

• Regulatory mechanisms:

  • Investigating post-translational modifications of UTP23 using modification-specific antibodies

  • Studying how environmental stresses affect UTP23 localization and function

  • Examining cell cycle-dependent regulation of UTP23-containing complexes

• Structural dynamics:

  • Developing conformation-specific antibodies to study structural changes in UTP23

  • Using antibodies as probes to track conformational changes during ribosome assembly

  • Combining with cryo-EM studies to position UTP23 within the 90S pre-ribosome

• Disease relevance:

  • Investigating UTP23's role in ribosomopathies or cancer using antibodies to track expression and localization

  • Developing antibodies against human UTP23 for potential diagnostic applications

  • Studying how mutations in UTP23 might contribute to disease phenotypes

• Therapeutic targeting:

  • Using antibodies to identify small molecule binding sites on UTP23

  • Developing inhibitory antibodies to study consequences of acute UTP23 inactivation

  • Exploring UTP23 as a potential target in proliferative disorders

• Technological applications:

  • Developing split-antibody systems for studying UTP23 interactions in living cells

  • Creating nanobodies against UTP23 for super-resolution microscopy

  • Utilizing antibodies in proximity labeling approaches to map the UTP23 interaction network

How can researchers integrate UTP23 antibody-based approaches with emerging technologies?

Integration of UTP23 antibody approaches with cutting-edge technologies offers exciting possibilities:

• Combination with CRISPR technologies:

  • Generate endogenously tagged UTP23 cell lines for antibody validation

  • Create UTP23 domain deletion mutants to test domain-specific antibodies

  • Perform CRISPR screens to identify factors affecting UTP23 localization or function, monitored by antibody-based assays

• Integration with spatial transcriptomics:

  • Use UTP23 antibodies in proximity labeling approaches to identify RNAs in the vicinity of UTP23

  • Combine with FISH techniques to visualize both UTP23 and associated RNAs

  • Map the spatial organization of UTP23-containing complexes within the nucleolus

• Single-molecule approaches:

  • Apply antibodies in single-molecule tracking experiments to monitor UTP23 dynamics

  • Use antibody-based fluorescence correlation spectroscopy to study complex formation

  • Perform single-molecule pull-downs to analyze the heterogeneity of UTP23-containing complexes

• Cryo-electron microscopy applications:

  • Use antibodies or antibody fragments as fiducial markers for UTP23 in cryo-EM studies of pre-ribosomes

  • Apply antibody labeling to locate UTP23 within the complex 90S pre-ribosome architecture

  • Combine with in situ cryo-electron tomography to visualize UTP23 in its native cellular context

• High-throughput screening applications:

  • Develop antibody-based assays to screen for compounds affecting UTP23 function

  • Create biosensor antibodies that report on UTP23 conformational changes

  • Use antibodies in protein-fragment complementation assays to monitor UTP23 interactions in living cells